scholarly journals Comparative evaluation on clinical success rate of prefabricated zirconia crowns and stainless steel crowns in primary molars

2021 ◽  
Vol 7 (3) ◽  
pp. 180-186
Author(s):  
A. K. Harshitha ◽  
H. T. Ajay Rao ◽  
K. Sundeep Hegde ◽  
Sharan S. Sargod ◽  
Shrivya Saloni Mahaveeran ◽  
...  
Keyword(s):  
Stainless Steel ◽  
Success Rate ◽  
Statistical Difference ◽  
Clinical Success ◽  
Clinical Success Rate ◽  
Primary Molars ◽  
Type I ◽  
Marginal Integrity ◽  
Gingival Health ◽  
Zirconia Crowns

To compare the clinical success rate of Prefabricated Zirconia crowns and stainless steel crowns on primary molars: It is an in-vivo study which was performed on 52 pulpally treated primary molars of children aged 4–9 years were randomly divided into two equal groups of stainless steel crown and Prefabricated Zirconia crowns. Tooth preparation was done according to the manufacturer’s recommendations and crowns were cemented. All crowns were cemented with Type I Glass ionomer cement (GIC) luting cement. Crowns were evaluated clinically for its crown retention, marginal integrity and gingival health at 3 months and 6 months.: Clinical success for stainless steel crowns and Prefabricated Zirconia crowns towards crown retention and marginal integrity were similar with no statistical difference between them. All Prefabricated Zirconia crowns showed healthy gingiva whereas 53.8% (14 out of 26) Stainless Steel crowns showed mild gingival inflammation at 3 and 6 months which was statistically significant (P ≤0.01). Both prefabricated zirconia and stainless steel crowns showed no statistical difference for crown retention and marginal integrity throughout the study. Gingival health was significantly higher for Prefabricated Zirconia crowns compared with stainless steel crowns. Therefore clinical success rate for Prefabricated Zirconia crowns were better when compared to stainless steel crowns. So Prefabricated Zirconia crowns can be considered as an esthetic alternative in future.

scholarly journals Evaluation of clinical success, parental and child satisfaction of stainless steel crowns and zirconia crowns in primary molars

2020 ◽  
Vol 9 (3) ◽  
pp. 1418
Author(s):  
MebinGeorge Mathew ◽  
KorishettarBasavaraj Roopa ◽  
AshuJagdish Soni ◽  
Md Muzammil Khan ◽  
Afreen Kauser
Keyword(s):  
Stainless Steel ◽  
Clinical Success ◽  
Primary Molars ◽  
Zirconia Crowns

Clinical Performance of Indirect Composite Onlays as Esthetic Alternative to Stainless Steel Crowns for Rehabilitation of a Large Carious Primary Molar

2016 ◽  
Vol 40 (5) ◽  
pp. 345-352 ◽  
Author(s):  
Hitesh Chander Mittal ◽  
Ashima Goyal ◽  
Krishan Gauba ◽  
Aditi Kapur
Keyword(s):  
Stainless Steel ◽  
Treatment Time ◽  
Clinical Performance ◽  
Resin Composite ◽  
Study Groups ◽  
Primary Molars ◽  
Primary Molar ◽  
Secondary Caries ◽  
Marginal Integrity ◽  
Gingival Health

Objective: The aim of the present study was to evaluate the clinical performance of indirect resin composite onlays (IRC onlay) compared to stainless steel crowns (SSCs), as an esthetic alternative for rehabilitation of extensively carious primary molars. Study design: Fifty pediatric patients each received either IRC onlay or SSC randomly on extensively carious endodontically treated primary molars. All the restorations were evaluated at baseline and then every 6 months till 36 months using ‘modified FDI criteria’ for retention, marginal integrity, occlusion, proximal contact, secondary caries and gingival health. The dental chair side treatment time and post-operative acceptability were also evaluated for both the groups. Results: The cumulative survival rate of IRC onlays was 82.9% compared to 90.7% for SSCs over a time period of 36 months. The difference between the two study groups at various time intervals in terms of retention, marginal integrity, secondary caries, proximal contact, occlusion and gingival health was not statistically significant (p>0.05). The IRC onlays required significantly less mean chair side treatment time and were preferred the most by parents and children as per VAS scores compared to SSCs. Conclusion: IRC onlays are an acceptable esthetic alternative to SSCs and may be considered for use in aesthetically conscious children/parents as per their preference.

scholarly journals Comparative evaluation of the efficacy of chitosan and formocresol as medicaments for pulpotomy in primary molars: A clinical pilot study

2021 ◽  
Vol 2 (2) ◽  
pp. 19-29
Author(s):  
Nihal R Kothari ◽  
S K Srinath ◽  
Sulakshana S ◽  
Aswathy T ◽  
Padmapriya S
Keyword(s):  
Success Rate ◽  
Clinical Success ◽  
Clinical Success Rate ◽  
Study Groups ◽  
Primary Molars ◽  
Chi Square ◽  
Chi Square Test ◽  
History Of ◽  
Group A ◽  
Group B

Aim: To compare the clinical and radiographic effectiveness of chitosan and formocresol as pulpotomy medicaments in primary molars. Methods: Children of age 4-8 years old, who were physically and mentally healthy without any known medical history of systemic conditions contraindicating pulp therapy with at least one deep carious primary molars indicated for pulpotomy, were recruited. Pulpotomies were performed on 64 teeth divided into 2 groups, Group A (chitosan) and Group B (formocresol), followed by stainless steel crowns. Evaluation of clinical and radiological success was done at 1, 3 and 6 months follow up. Chi Square Test was used to compare the clinical and radiological parameters between study groups at different time intervals (p < 0.05) Results: Clinical success rate in both groups was 96.6% and radiographic success rate in chitosan was 96.6%, but formocresol was 89.6%. Conclusions: Chitosan was found to be an effective medicament for pulpotomy in primary molars. While chitosan also showed improved success rate compared to formocresol, it was not statistically significant.

scholarly journals Clinical Evaluation and Comparison of Stainless Steel Crowns and Zirconia Crowns in Primary Molars- A Study Protocol

2021 ◽  
pp. 64-69
Author(s):  
Monika M. Khubchandani ◽  
Nilima Thosar
Keyword(s):  
Stainless Steel ◽  
Clinical Success ◽  
Therapeutic Option ◽  
Controlled Trial ◽  
Study Groups ◽  
Primary Objective ◽  
Primary Molars ◽  
Zirconia Crowns ◽  
One Year ◽  
Periodic Interval

Aim: The present study will be undertaken to evaluate and compare the clinical success of stainless steel crowns and zirconia crowns in carious primary molars. Study Design: Randomized controlled trial. Place and Duration of the Study: Department of Pedodontics & Preventive Dentistry, Sharad Pawar Dental College & Hospital, Duration- One year Methodology: In this Split-mouth, 12 months study, set of primary molars in 4-9 years old children will be restored with stainless steel crown and zirconia crown. The primary objective is the assessment of clinical success by evaluating pain, swelling and pathologic mobility at baseline, 1, 3, 6 and 12 months interval. The secondary objectives are to assess the level of parental satisfaction by applying fivepoint likert scale and evaluate the gingival condition by recording Sillness and Loe Plaque index (PI) and Loe and Silness Gingival Index (GI) of study groups at periodic interval of 1, 3, 6 and 12 months. Results: The results of the present study will investigate the effectiveness of two types of pediatric full coverage restorations for management of extensive caries in primary molars. Conclusion: The findings of the present research would help the patient and practitioners to select appropriate therapeutic option.

scholarly journals Comparative Evaluation of the Success Rate of Pulpotomy in Primary Molars Using Ferric Sulphate (FS) and Mineral Trioxide Aggregate (MTA): A Clinical and Radiographic Study

2021 ◽  
pp. 356-363
Author(s):  
Yogesh Somwanshi ◽  
Pankaj Chavhan ◽  
Arun Sajjanar ◽  
Snehal Ughade ◽  
Nutan Gutte ◽  
...  
Keyword(s):  
Success Rate ◽  
Clinical Success ◽  
Mineral Trioxide Aggregate ◽  
Clinical Success Rate ◽  
Primary Molars ◽  
Ferric Sulphate ◽  
Primary Molar ◽  
Group A ◽  
Group B

Purpose: The aim of this present study was to observe clinical, radiographic response of pulp to Ferric Sulphate and Mineral Trioxide Aggregate when used as pulpotomy agent in primary molars. Materials and Methods: Sixty restorable primary molars were selected for the study. The children were chosen who require minimum two pulpotomies in either arch preferably each on the opposite side (i.e. right and left). Primary molars on the right side of the patient were assigned to Ferric Sulphate (FS) (Group A) and left side was assigned for the Mineral Trioxide Aggregate (MTA) (Group B). Statistical analysis was done for pain, swelling, sinus, and fistula and for internal resorption, furcation radiolucency and periapical pathology using the chi-square test. Results: outcome of the present study was observed at 3 month interval and after 6 months. The clinical success rate for MTA (AQUA) and ferric sulphate during 3 and 6 month follow up was 100%. The radiographic follow up of MTA was 100% during 3 and 6 month, whereas it was 96.6% for 3 and 6 month follow up with respect to ferric sulphate. There were no significant differences in the clinical (p>0.1) and radiographic (p>0.98) success rates among both the groups. Conclusion: ferric sulphate was found to be equally effective when compared with MTA. Radiographic success rate was lower for Ferric sulphate (Group A) than that of MTA (Group B) with occurrence of one internal resorption seen with first primary molar.

Clinical effectiveness of high dose versus standard dose of meropenem in ventilator-associated pneumonia caused by multidrug-resistant bacteria: a randomized single-blind clinical trial

2020 ◽  
Vol 20 ◽  
Author(s):  
Mahila Monajati ◽  
Shahram Ala ◽  
Masoud Aliyali ◽  
Roya Ghasemian ◽  
Fatemeh Heidari ◽  
...  
Keyword(s):  
Success Rate ◽  
Sofa Score ◽  
Dose Group ◽  
Clinical Success ◽  
Standard Dose ◽  
Clinical Success Rate ◽  
High Dose Group ◽  
Resistant Bacteria ◽  
High Dose ◽  
Ventilator Associated Pneumonia

Background: Meropenem standard doses are based on the minimum inhibitory concentration of sensitive pathogens and the pharmacokinetic parameter of not critically ill patients. We compared the efficacy of high versus standard dose of meropenem in ventilator-associated pneumonia (VAP). Methods: 24 out of 34 eligible patients were randomized to receive meropenem 3 g q8h (high dose group, 11 patients) or 2 g q8h (standard dose group, 13 patients) as a 3h infusion. Primary outcome was considered as clinical success that was defined as stable hemodynamic, improved sequential organ failure assessment (SOFA) score, stable or improved PaO2/FiO2 after 7 days. A sputum culture was taken before intervention. Results: Clinical success rate was not significantly different between the high and standard dose group (54.5% vs. 38.5%, P= 0.431). There was a significant difference in reduction of clinical pulmonary infection score (CPIS) compared to high dose with standard group (P=0.038). SOFA score declined significantly in high dose group through the study (P=0.006). A shorter duration of VAP treatment was recorded in high dose group (P=0.061). We did not observe any significant adverse event related to meropenem. Acinetobacter spp. (34.8%), Klebsiella spp. (32.6%) and, Pseudomonas aeruginosa (19.5%) isolated more frequently from sputum cultures. Conclusion: Treatment with high dose of meropenem seems to be safe. However, it did not provide significantly higher clinical success rate in comparison with the standard dose, but could be considered as an appropriate empirical treatment in patients with severe infection due to reducing in SOFA and CPIS.

Ferric sulfate as pulpotomy agent in primary teeth: twenty month clinical follow-up

2000 ◽  
Vol 24 (4) ◽  
pp. 269-272 ◽  
Author(s):  
Hamijeta Ibricevic ◽  
Qumasha Al-Jame
Keyword(s):  
Success Rate ◽  
Primary Teeth ◽  
Root Resorption ◽  
Clinical Success ◽  
Clinical Success Rate ◽  
Ferric Sulfate ◽  
Primary Molar ◽  
Molar Teeth ◽  
The Moment

Seventy primary molar teeth, carious exposed, symptom free, without any sign of root resorption in children aged from 3 to 6 years (main age 4.3yr) were treated with conventional pulpotomy procedures. Ferric sulfate 15.5% solution (applied for 15 second for 35 teeth) and formocresol solution (five minute procedure of Buckley's formula for next 35 teeth) have been used as pulpotomy agents. In both groups, pulp stumps were covered with zinc-oxide eugenol paste. Permanent restorations were stainless steel crowns. Clinical check up was every three-months and radiographic follow-up time was six and twenty months after treatment. Our results within this period revealed 100% clinical success rate in both groups. Radiographic success rate was in both groups 97.2%, while in 2.8% cases has shown internal root resorption. On the basis of these results, we can recommend ferric sulfate as a pulpotomy agent in primary teeth in substitution for formocresol at the moment.

Comparison of alteplase and urokinase for pharmacomechanical thrombolysis of clotted hemodialysis access

2018 ◽  
Vol 20 (5) ◽  
pp. 501-506 ◽  
Author(s):  
Ru Yu Tan ◽  
Suh Chien Pang ◽  
Swee Ping Teh ◽  
Kian Guan Lee ◽  
Tze Tec Chong ◽  
...  
Keyword(s):  
Success Rate ◽  
Vascular Access ◽  
Clinical Success ◽  
Univariate Analysis ◽  
Clinical Success Rate ◽  
Skin Dose ◽  
Hemodialysis Access ◽  
Procedure Time ◽  
Technical Success Rate ◽  
Tertiary Teaching

Background: Percutaneous pharmacomechanical thrombolysis is increasingly used to salvage thrombosed hemodialysis access. We aim to evaluate the effectiveness of alteplase compared to urokinase in percutaneous pharmacomechanical thrombolysis clotted access. Methods: Records of patients who underwent pharmacomechanical thrombolysis at Interventional Nephrology Suite in a tertiary teaching hospital from 1 January 2016 to 31 December 2016 were reviewed. Technical and clinical success rates, thrombosis-free and cumulative survivals, procedure time, and radiation dose imparted to patients were compared for pharmacomechanical thrombolysis with urokinase versus alteplase. Results: A total of 122 incident patients underwent pharmacothrombolysis (n = 53 for urokinase, n = 69 for alteplase) during the study period. The mean dose of urokinase and alteplase used was 176,897 ± 73,418 units and 3.7 ± 0.8 mg, respectively. Pharmacomechnical thrombolysis using urokinase versus alteplase has similar technical success rate (98.1% vs 97.1%, p = 0.599), clinical success rate (88.7% vs 97.1%, p = 0.068), complication rate (9.4% vs 13.0%, p = 0.373), and primary patency rates at 3 months (57.1% vs 70.1%, p = 0.106). Thrombosis-free survivals of the vascular access were 113.2 (35.3, 196) days versus 122 (84, 239) days (p = 0.168). Cumulative survivals were 239 (116, 320) vs 213 (110.5, 316.5) days (p = 0.801). Procedure time, fluoroscopy time, skin dose, and dose were significantly lower for pharmacomechanical thrombolysis using alteplase compared to urokinase (p = 0.045, p < 0.0001, p = 0.006, p = 0.001, respectively). Stenting was found to be associated with successful dialysis following thrombolysis on univariate analysis (odds ratio: 9.167, 95% confidence interval: 1.391–19.846, p = 0.021), although this was no longer significant in multivariate analysis (p = 0.078). Conclusion: Alteplase is an effective and safe alternative to urokinase for pharmacomechanical thrombolysis of clotted vascular access.

Sign in / Sign up

Export Citation Format

Share Document